Thread by @drharshvardhan

ZyCoV-D, the plasmid DNA vaccine designed & developed by @ZydusUniverse & partially funded by @DBTIndia has initiated Phase I/ II clinical trials in healthy subjects, making it the first indigenously developed vaccine for #COVID19 to be administered in humans in India.@IndiaDST

The adaptive Phase I/ II dose-escalation, multi-centric study will assess the safety & immunogenicity of the #vaccine. The human dosing of the vaccine marks a key milestone since the launching of the accelerated vaccine development programme for #COVID19 in Feb 2020. @DBTIndia

This is an important milestone for #AtmaNirbharBharat. I hope that the vaccine continues to show positive outcomes as it has done so far in the pre-clinical phase where it was found to be safe, immunogenic and well-tolerated.

@DBTIndia @IndiaDST @ICMRDELHI

.@DBTIndia has partnered with @ZydusUniverse to address rapid development of an indigenous #vaccine for #COVID19 under the National Biopharma Mission. This partnership with Zydus is to serve the country’s need for a vaccine to fight the dreaded pandemic.
@IndiaDST @ICMRDELHI